The use of off-label medicines is an unexplored area for healthcare priority setting, though it is common practice in countries and can have a significant positive or negative effect on health outcomes and the efficiency of health care systems. It is therefore important to have a rational an

t is an uncomfortable question that, in today’s world, is often asked by expectant mothers who had more than one male partner at the time they became pregnant. Who is the father?With more than half of births to women under 30 now out of wedlock, it is a question that may arise more often.Now blood t

Two days after Debra Demidon underwent in vitro fertilization, she gained more than 30 pounds in fluid and suddenly was struggling to breathe.Doctors diagnosed severe ovarian hyperstimulation syndrome (OHSS), a complication seen in some women who undergo fertility treatment. It landed Ms. Demidon in

(Reuters) – An experimental drug from Novartis may help up to half of heart failure patients for whom no effective treatment is available, although the evidence so far is indirect.Results of a mid-stage clinical trial of the drug known as LCZ696, unveiled on Sunday, gauged its effectiveness by measu

Nonthaburi, Thailand | November 25, 2022 – The Health Intervention and Technology Assessment Program (HITAP) announced the completion of the first Technical Workshop on Infectious Disease Modelling. Research staff from the London School of Hygiene and Tropical Medicine (LSHTM) with joint appointment

In the death of Professor Sir Mike David Rawlins, founding chairman of the National Institute for Health and Care Excellent (NICE), who passed away at 81, the world of health and social care guidance and medicine evaluation community has lost one of its greatest leaders. Over his

Alcohol addiction has been identified as one of the leading causes of disability adjusted life years in Thailand. This umbrella review aims to provide a comprehensive overview of the interventions that are effective in the prevention and treatment of harmful alcohol use, and to provide a comparison

HITAP was invited to attend the “Strengthening Health and Disease Modelling for Public Health Decision Making” organised by the Bill and Melinda Gates Foundation (BMGF) and Wellcome on June 7–8, 2023 in Kigali, Rwanda. It brought together 110 virtual and on-site attendees, with 76 on-site modellers,

Countries across Asia are increasingly turning to health technology assessment (HTA) to ensure healthcare decisions are guided by appropriate evidence. However, many still face challenges in institutionalizing HTA, including building technical expertise, applying economic evaluation in decision-maki

Kinanti Khansa Chavarina is an Associate at the International Unit of the Health Intervention and Technology Assessment Program (HITAP) Foundation in Thailand. Her work focuses on health policy and systems research, such as scoping and systematic reviews, qualitative analysis, and economic evaluation. Her research interests include health policy, h